Holen Sie sich die Stockscreener-App
8.18
2.25%
0.18
Handel nachbörslich:
7.92
-0.26
-3.18%
Schlusskurs vom Vortag:
$8.00
Offen:
$8
24-Stunden-Volumen:
3.44M
Relative Volume:
2.16
Marktkapitalisierung:
$1.30B
Einnahmen:
$93.95M
Nettoeinkommen (Verlust:
$-129.87M
KGV:
-9.0889
EPS:
-0.9
Netto-Cashflow:
$-202.88M
1W Leistung:
-17.62%
1M Leistung:
-6.51%
6M Leistung:
-27.16%
1J Leistung:
+59.77%
1-Tages-Spanne:
$7.485
$8.20
1-Wochen-Bereich:
$7.115
$10.06
52-Wochen-Spanne:
$5.04
$16.73
Wave Life Sciences Ltd Stock (WVE) Company Profile
Firmenname
Wave Life Sciences Ltd
Sektor
Branche
Telefon
617-949-2900
Adresse
7 STRAITS VIEW, SINGAPORE
Vergleichen Sie WVE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
WVE
Wave Life Sciences Ltd
|
8.18 | 1.53B | 93.95M | -129.87M | -202.88M | -0.90 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-04 | Eingeleitet | Canaccord Genuity | Buy |
| 2025-07-28 | Eingeleitet | Oppenheimer | Outperform |
| 2025-07-16 | Eingeleitet | Citigroup | Buy |
| 2025-06-11 | Fortgesetzt | Raymond James | Outperform |
| 2025-04-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-04-08 | Eingeleitet | Wedbush | Outperform |
| 2025-02-25 | Eingeleitet | Jefferies | Buy |
| 2024-10-16 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-09-27 | Fortgesetzt | JP Morgan | Overweight |
| 2024-09-19 | Eingeleitet | B. Riley Securities | Buy |
| 2024-09-09 | Eingeleitet | JP Morgan | Overweight |
| 2024-05-15 | Eingeleitet | Wells Fargo | Overweight |
| 2023-12-19 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2023-07-05 | Eingeleitet | Raymond James | Outperform |
| 2023-05-24 | Herabstufung | Jefferies | Buy → Hold |
| 2020-12-15 | Fortgesetzt | H.C. Wainwright | Buy |
| 2020-10-23 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2019-12-31 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2019-11-01 | Eingeleitet | Guggenheim | Buy |
| 2019-07-15 | Eingeleitet | Cowen | Market Perform |
| 2019-04-17 | Bestätigt | H.C. Wainwright | Buy |
| 2018-08-07 | Eingeleitet | Stifel | Buy |
| 2018-07-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-03-19 | Bestätigt | Mizuho | Buy |
| 2017-02-15 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-11-10 | Fortgesetzt | Leerink Partners | Outperform |
| 2015-12-07 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2015-12-07 | Eingeleitet | Jefferies | Buy |
| 2015-12-07 | Eingeleitet | Leerink Partners | Outperform |
| 2015-12-07 | Eingeleitet | Sun Trust Rbsn Humphrey | Buy |
Alle ansehen
Wave Life Sciences Ltd Aktie (WVE) Neueste Nachrichten
Wave Life Sciences stock price target lowered to $16 at Jones Trading - Investing.com
Wave Life says data are positive but stock wavers - BioWorld MedTech
Leerink Partners raises WAVE Life Sciences stock price target to $26 on AATD data - Investing.com
Assessing Wave Life Sciences' (WVE) RNA Editing Pipeline: Is the Stock Undervalued Amid Clinical Progress and Financial Challenges? - AInvest
Transcript : Wave Life Sciences Ltd.Special Call - MarketScreener
Using Ichimoku Cloud for Wave Life Sciences Ltd. technicalsTreasury Yields & Daily Market Momentum Tracking - Newser
Why Is GSK Partner Wave Life Sciences Stock Trading Lower On Wednesday? - Benzinga
WVE: HC Wainwright & Co. Reiterates Buy Rating with $22 PT | WVE Stock News - GuruFocus
Wave Life Sciences Shares Drop Following WVE-006 Trial Update - MSN
Wave Life Sciences Says RNA-Editing Therapy Achieves 'Durable' Serum AAT Protein Production - MarketScreener
Why Is Wave Life Sciences Stock (WVE) Down 20% Today? - TipRanks
Wave Life Sciences reports promising data for AATD treatment - Investing.com
Wave Life Sciences drops after trial data for GSK-partnered RNA-editing therapy (WVE:NASDAQ) - Seeking Alpha
Wave Life Sciences Announces Positive Results for WVE-006 Study - TipRanks
Wave Life Sciences stock tumbles after WVE-006 trial update - Investing.com
Wave Life Sciences Announces Positive Update from Ongoing RestorAATion-2 Trial of WVE-006 in Alpha-1 Antitrypsin Deficiency - The Manila Times
Wave Life Sciences Announces Positive Update from Ongoing - GlobeNewswire
Breakthrough: First-Ever Restored AAT Production of 20.6µM Achieved in Wave's AATD Treatment Trial - Stock Titan
Will Wave Life Sciences Ltd. rebound enough to break evenInsider Selling & Daily Market Momentum Tracking - Newser
Momentum divergence signals in Wave Life Sciences Ltd. chartEarnings Risk Report & Low Risk Profit Maximizing Plans - Newser
How institutional ownership impacts Wave Life Sciences Ltd. stock2025 Historical Comparison & Reliable Price Breakout Signals - Newser
What indicators show strength in Wave Life Sciences Ltd.Earnings Overview Summary & Weekly Watchlist for Consistent Profits - Newser
Wave Life Sciences Ltd. stock daily chart insightsEarnings Risk Report & Fast Gain Stock Tips - Newser
Why Wave Life Sciences Ltd. is moving todayShort Setup & Weekly Chart Analysis and Guides - Newser
Using data tools to time your Wave Life Sciences Ltd. exitJuly 2025 EndofMonth & Trade Opportunity Analysis Reports - Newser
Is Wave Life Sciences Ltd.’s ROE strong enough2025 Momentum Check & Advanced Technical Analysis Signals - khodrobank.com
Published on: 2025-09-03 07:48:31 - khodrobank.com
Chart based analysis of Wave Life Sciences Ltd. trendsPrice Action & Free Technical Confirmation Trade Alerts - Newser
Intraday pattern recognizer results for Wave Life Sciences Ltd.July 2025 WrapUp & Fast Gain Stock Tips - Newser
How to build a custom watchlist for Wave Life Sciences Ltd.Wall Street Watch & Safe Capital Growth Tips - Newser
What is the dividend yield of Wave Life Sciences Ltd.July 2025 Macro Moves & Safe Entry Trade Reports - khodrobank.com
How to integrate Wave Life Sciences Ltd. into portfolio analysis toolsExit Point & Risk Controlled Swing Alerts - Newser
Will Wave Life Sciences Ltd. benefit from sector rotationQuarterly Market Summary & Accurate Entry/Exit Alerts - خودرو بانک
Fibonacci Retracement Aligns with Support in Wave Life Sciences Ltd.Portfolio Gains Report & Free Technical Confirmation Trade Alerts - beatles.ru
Wave Life Sciences Ltd. Builds Base for Possible Rebound getLinesFromResByArray error: size == 0 - thegnnews.com
Published on: 2025-09-01 00:07:21 - Newser
Will earnings trigger a reversal in Wave Life Sciences Ltd.Market Risk Summary & Weekly Momentum Stock Picks - Newser
Real time pattern detection on Wave Life Sciences Ltd. stockWeekly Market Report & Weekly Consistent Profit Watchlists - Newser
Will breakout in Wave Life Sciences Ltd. lead to full recoveryMarket Risk Analysis & Low Risk Investment Opportunities - Newser
Detecting price anomalies in Wave Life Sciences Ltd. with AIWeekly Stock Summary & Consistent Growth Equity Picks - Newser
Can machine learning forecast Wave Life Sciences Ltd. recovery2025 Momentum Check & Real-Time Market Trend Scan - Newser
What does recent volatility data suggest for Wave Life Sciences Ltd.Quarterly Performance Summary & Reliable Price Breakout Signals - Newser
Quant Strategy Flags Wave Life Sciences Ltd. for EntryMarket Risk Analysis & Fast Exit and Entry Trade Guides - beatles.ru
What makes Wave Life Sciences Ltd. stock price move sharplyJuly 2025 Sector Moves & Daily Entry Point Trade Alerts - Newser
Finanzdaten der Wave Life Sciences Ltd-Aktie (WVE)
Umsatz
Nettogewinn
Free Cashflow
ENV
Wave Life Sciences Ltd-Aktie (WVE) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| BOLNO PAUL | President and CEO |
Aug 22 '25 |
Sale |
10.10 |
217,351 |
2,194,810 |
121,000 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):